Assertio Holdings | DEPO - Net Income

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $-2.92M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Cara Therapeutics USD -5.53M 621K Sep/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.24B 119M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -36.08M 978K Dec/2025
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025